Pharmananogene Ikerketa Taldea

• Beloqui A, MA Solinís, A del Pozo-Rodríguez, A Rodríguez-Gascón, A des Rieux, V Preat  Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier Journal of Controlled Release,  2013;  166,  115 - 123
• Ruiz de Garibay AP, Solinís Aspiazu MA, Rodríguez Gascón A, Ganjian H, Fuchs R.  Role of endocytic uptake in transfection efficiency of solid lipid nanoparticles-based nonviral vectors Journal of Gene Medicine,  2013;  15,  427 - 440
• del Pozo-Rodríguez A, Delgado D, Rodríguez-Gascón A, Solinís MA  Lipid nanoparticles as drug/gen delivery systems to the retina Journal of Ocular Pharmacology and Therapeutics,  2013;  29,  173 - 188
• Ruiz de Garibay AP, Solinís MA, Rodríguez-Gascón A.  . Gene Therapy for Fabry Disease: A Review of the Literature Biodrugs,  2013;  27,  237 - 246
• Beloqui A, Coco R, Alhouayek M, Solinís MA, Rodríguez-Gascón A, Muccioli GG, Préat V.  Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis International Journal of Pharmaceutics,  2013;  454,  775 - 783
• Humphreys L, Moll AG, Rueda J, Rodríguez-Gascón A, Fernández JM, Fernández E.  Novel vehicle for exploring networks dynamics in excitable tissue Neurocomputing,  2013;  114,  9 - 14
• Calvo B, Gómez P  Requirements for comparability of biosimilars Chemistry Today,  2013;  31,  44 - 48
• Delgado D, del Pozo-Rodríguez A, Solinís MA, Bartkowiak A, Rodríguez-Gascón A.  New gene delivery system based on oligochitosan and solid lipid nanoparticles: ‘In vitro' and ‘in vivo' evaluation. European Journal of Pharmaceutical Sciences,  2013;  50,  484 - 491
• Beloqui A, MA Solinís, A Delgado, C Evora, A del Pozo-Rodríguez, A Rodríguez-Gascón  Biodistribution of Nanostructured Lipid Carriers (NLCs) after intravenous administration to rats: influence of technological factors European Journal of Pharmaceutics and Biopharmaceutics,  2013;  84,  309 - 314